Ignite Creation Date:
2025-12-25 @ 3:25 AM
Ignite Modification Date:
2026-02-26 @ 6:28 AM
Study NCT ID:
NCT02243605
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-08
First Post:
2014-09-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Ewing Sarcoma | View |
| None | Metastatic Osteosarcoma | View |
| None | Recurrent Ewing Sarcoma | View |
| None | Recurrent Osteosarcoma | View |
| None | Stage III Osteosarcoma AJCC v7 | View |
| None | Stage IV Osteosarcoma AJCC v7 | View |
| None | Stage IVA Osteosarcoma AJCC v7 | View |
| None | Stage IVB Osteosarcoma AJCC v7 | View |
| None | Unresectable Ewing Sarcoma | View |
| None | Unresectable Osteosarcoma | View |
Keywords: